E-resources
-
Moriyama, Saya; Adachi, Yu; Sato, Takashi; Tonouchi, Keisuke; Sun, Lin; Fukushi, Shuetsu; Yamada, Souichi; Kinoshita, Hitomi; Nojima, Kiyoko; Kanno, Takayuki; Tobiume, Minoru; Ishijima, Keita; Kuroda, Yudai; Park, Eun-Sil; Onodera, Taishi; Matsumura, Takayuki; Takano, Tomohiro; Terahara, Kazutaka; Isogawa, Masanori; Nishiyama, Ayae; Kawana-Tachikawa, Ai; Shinkai, Masaharu; Tachikawa, Natsuo; Nakamura, Shigeki; Okai, Takahiro; Okuma, Kazu; Matano, Tetsuro; Fujimoto, Tsuguto; Maeda, Ken; Ohnishi, Makoto; Wakita, Takaji; Suzuki, Tadaki; Takahashi, Yoshimasa
Immunity (Cambridge, Mass.), 08/2021, Volume: 54, Issue: 8Journal Article
Antibody titers against SARS-CoV-2 slowly wane over time. Here, we examined how time affects antibody potency. To assess the impact of antibody maturation on durable neutralizing activity against original SARS-CoV-2 and emerging variants of concern (VOCs), we analyzed receptor binding domain (RBD)-specific IgG antibodies in convalescent plasma taken 1–10 months after SARS-CoV-2 infection. Longitudinal evaluation of total RBD IgG and neutralizing antibody revealed declining total antibody titers but improved neutralization potency per antibody to original SARS-CoV-2, indicative of antibody response maturation. Neutralization assays with authentic viruses revealed that early antibodies capable of neutralizing original SARS-CoV-2 had limited reactivity toward B.1.351 (501Y.V2) and P.1 (501Y.V3) variants. Antibodies from late convalescents exhibited increased neutralization potency to VOCs, suggesting persistence of cross-neutralizing antibodies in plasma. Thus, maturation of the antibody response to SARS-CoV-2 potentiates cross-neutralizing ability to circulating variants, suggesting that declining antibody titers may not be indicative of declining protection. Display omitted •Qualitative changes in plasma neutralizing antibody are longitudinally analyzed•Affinity-matured antibodies with resistance to variants are durably maintained•Neutralizing potency and breadth to SARS-CoV-2 variants increase with time•Serological immunity evolves with time to counter SARS-CoV-2 variants Antigenic drifts in SARS-CoV-2 variants permit escape from neutralizing antibody in COVID-19 convalescent plasma. Moriyama et al. reveal the evolution of serological immunity with time that counters SARS-CoV-2 variants via affinity maturation and durable elicitation of IgG antibodies that are resistant to viral escape.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.